Sean Sullivan
Company: Arcturus Therapeutics
Job title: Executive Director
Seminars:
Immunogenicity Characterization of mRNA Vaccines 2:30 pm
Preliminary preclinical results for second generation vaccines designed with improved anti-viral immunogenicity exhibited cross neutralization against alpha, beta, gamma and delta circulating viral variants in mice and non-human primates Rhesus macaque immunogenicity studies showed high neutralizing antibody titers after two prime injections 28 days apart. A further increase in neutralizing antibody titers were observed with…Read more
day: Pre-Conference Focus Day: Deep Dive into mRNA Characterization & Discovery